During the past 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Co's average Dividends Per Share Growth Rate was -30.40% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 5.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 11.70% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 70.50% per year. The lowest was -26.10% per year. And the median was 11.90% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Dividend Yield % Chart
Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data
FRA:GU5 vs MCK, COR, CAH: Dividend Yield % Comparison
For the Medical Distribution subindustry, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Dividend Yield % vs Medical Distribution Industry
Guangzhou Baiyunshan Pharmaceutical Holdings Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
HKD 0.516200
2026-06-12
2026-06-16
2026-07-17
Cash Dividend
semi-annually
HKD:EUR 0.109231
HKD 0.439900
2025-08-29
2025-09-02
2025-09-26
Cash Dividend
semi-annually
HKD:EUR 0.110204
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) has a Dividend Yield % of 6.54% as of Jun. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. This is 225% above median its historical median of 2.01. Over the past decade, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Dividend Yield % has ranged from 0.65 to 6.58. According to the industry distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #25 out of 69 companies in the Medical Distribution industry, placing it in the top 36.2%.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co's Dividend Yield % too high?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Dividend Yield % of 6.54% is 225% above median its 10-year median of 2.01. Over the past 10 years, this metric has ranged from a low of 0.65 to a high of 6.58. The Medical Distribution industry median Dividend Yield % is 2.86. Guangzhou Baiyunshan Pharmaceutical Holdings Co's value of 6.54% is 128.7% above this industry median. Based on the distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #25 out of 69 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Guangzhou Baiyunshan Pharmaceutical Holdings Co has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Baiyunshan Pharmaceutical Holdings Co's Dividend Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #25 out of 69 companies for Dividend Yield %. This puts Guangzhou Baiyunshan Pharmaceutical Holdings Co in the upper half of its industry. The industry median Dividend Yield % is 2.86. Guangzhou Baiyunshan Pharmaceutical Holdings Co's value of 6.54% is 128.7% above this benchmark. Historically, Guangzhou Baiyunshan Pharmaceutical Holdings Co's own Dividend Yield % has ranged from 0.65 to 6.58 over the past decade. While the company's 10-year median is 2.01 vs. the industry median of 2.86, Guangzhou Baiyunshan Pharmaceutical Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Distribution company?
The median Dividend Yield % among Medical Distribution companies is 2.86, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Dividend Yield % of 6.54% is 128.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. For the Medical Distribution industry, the median Dividend Yield % is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Dividend Yield % is 6.54%, which is 225% above median its own 10-year median of 2.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.36, compared to a current price of €1.57 — trading 33.5% below its estimated fair value. The current Dividend Yield % is 6.54%, which is 225% above median its 10-year median of 2.01 and 128.7% above the Medical Distribution industry median of 2.86. Guangzhou Baiyunshan Pharmaceutical Holdings Co's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5), the current Dividend Yield % is 6.54% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) Overvalued in 2026?
Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co stock appears to be undervalued.
The current stock price of €1.57 is trading 33.5% below its estimated GF Value™ of €2.36.
GuruFocus considers Guangzhou Baiyunshan Pharmaceutical Holdings Co to be Significantly Undervalued.
Key valuation signals for FRA:GU5:
Dividend Yield %: 6.54% (225% above median its 10-year median of 2.01)
GF Value™: €2.36 vs. price of €1.57 (33.5% below fair value)
Industry Position: 128.7% above the Medical Distribution median (#25 of 69)
No single metric tells the full story. See the FRA:GU5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.
72GF Score
Get the complete analysis for FRA:GU5
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:GU5 has been successfully added to your 
